Tag Archives: FDA

Advocate Perspective

Excerpted from the Breast Cancer Deadline 2020® 2nd Annual Progress Report In NBCC’s 2011 Baseline Report we gave our advocate perspective on the state of breast cancer. As that perspective described, there has not been sufficient progress in any area … Continue reading

Posted in Breast Cancer Deadline 2020, National Breast Cancer Coalition | Tagged , , , , , , , , , | Comments Off

T-DM1: ASCO Showcases a Victory for Science, But Is It a Victory for Women?

By Laura Nikolaides, Director of Research and Quality Care Programs Laura Nikolaides answers questions at the Project LEAD® Advanced Topics session during the NBCC 2012 Annual Advocate Summit. I just got back from spending the weekend in Chicago at the … Continue reading

Posted in Breast Cancer Deadline 2020 | Tagged , , , , , , , , , , , , , , , , | 9 Comments